Clinical Trial Update: Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of aramchol for HIV-associated nonalcoholic fatty liver disease and lipodystrophy has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Aramchol

Snippet

Sponsor: University of California, San Diego | Conditions: Nonalcoholic Fatty Liver Disease, HIV | Phase 2 | Status: COMPLETED | Results posted: 2019-08-21